ATXS - Astria Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
11.84 0.1 (0.84%)	---	---	---	-0.12 (-1.01%)	0.18 (1.54%)	0.04 (0.34%)	0.04 (0.34%)

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.57
Diluted EPS:: -0.57
Basic P/E:: -20.9474
Diluted P/E:: -20.9474
RSI(14) 1m:: 100.0
VWAP:: 11.94
RVol:: 7.2328

Events

Period	Kind	Movement	Occurred At
Day	Rvol 5 increase day	rvol 5.01, 11.95 +0.11 (+0.93%)	Oct 15 14:57
Day	Rvol 2 increase day	rvol 2.02, 11.89 +0.04 (+0.38%)	Oct 15 11:14
1m	Price increase 1m	11.85 +0.13 (+1.11%)	Oct 15 09:30